On the other hand, a different role of IL-6 has been proposed in the context of obesity: in a randomized placebo-controlled trial, abdominally obese adults were treated with tocilizumab, the monoclonal antibody against IL-6 receptor, or with placebo, with either exercise or no exercise [45]. This evidence concerns the gene IL6 and obesity disorder.